Artificial pancreas approved by FDA! Avoid frequent injections

Author: Tang Jinghong recently, the FDA approved the artificial pancreas system developed by the University of Virginia, which can automatically monitor and regulate blood glucose level The artificial pancreas, called control IQ, can track blood sugar levels through a continuous blood glucose monitor (dexcomg6cgm) and automatically deliver insulin as needed Since then, patients no longer need to prick their hands to detect blood sugar level, nor need to inject insulin frequently Artificial pancreas source: the approval of the UVA FDA is based on the results of a clinical trial published in the New England Journal of medicine It is found that the new artificial pancreas system is more effective than the existing treatment in controlling the blood glucose level of type 1 diabetic patients The system can improve the blood glucose control 24 hours a day Doi: 10.1056/nejmoa1907863 168 patients aged 14 years or over with type 1 diabetes participated in the study They were randomly assigned to use an artificial pancreatic system or a sensor enhancement pump (SAP) with a continuous blood glucose monitor and insulin pump, which did not automatically regulate insulin all day The researchers found that the duration of blood glucose at the target level was significantly longer for users of the artificial pancreas system, while the duration of reaching the appropriate blood glucose range in the sap group did not change during the six-month trial period Moreover, compared with SAP group, the artificial pancreas system also performed better in regulating blood glucose time During the study, no serious hypoglycemic events occurred in both groups This ten-year research has been successfully transformed into clinical practice, and a new generation of automatic and interactive blood glucose control system has been born It can seamlessly integrate continuous blood glucose sensor, insulin pump and intelligent control algorithm, better manage type 1 diabetes, help type 1 diabetes patients simplify blood glucose control steps, and optimize blood glucose control effect I look forward to an early public day Reference: [1] FDA approved UVA developed artificial areas [2] six month randomized, multicenter trial of closed loop control in type 1 diabetes